MedPath

A study to compare effect of three common locally applied medicines in alopecia areata (a disease causing patchy hair loss) of scalp.

Not Applicable
Conditions
Health Condition 1: L638- Other alopecia areata
Registration Number
CTRI/2019/02/017483
Lead Sponsor
Amit Bahuguna
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Alopecia Areata (AA) patients aged 12â??45 years

2.AA of scalp with a Severity of Alopecia Tool (SALT) score of S1

3.Patients having 03 or less patches

4.Consent to be part of the study, photograph & regular follow up

Exclusion Criteria

1.History of side effects to Bimatoprost, Mometasone or Tacrolimus.

2.Patients treated earlier within 3 months of the study

3.Patients with any evidence of atrophy in the lesions

4.Patients with alopecia totalis, alopecia universalis or ophiasis pattern of AA

5.Patients with history of spontaneous hair re-growth

6.Pregnant or lactating patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
i.Hair regrowth- 5 point semi-quantitative score, regrowth scale (RGS)and Global assessment of 100% <br/ ><br>Timepoint: 24 weeks
Secondary Outcome Measures
NameTimeMethod
AtrophyTimepoint: 24 Weeks;relapse <br/ ><br>Timepoint: 24 weeeks
© Copyright 2025. All Rights Reserved by MedPath